TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
What this study shows
Akt directly phosphorylates and inactivates TSC2, disrupting the TSC1-TSC2 complex and releasing its inhibition of mTOR - the link between growth-factor/insulin signaling and mTORC1 activation.
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: Human cell lines) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | Human cell lines |
| Journal | Nature Cell Biology |
| Year | 2002 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1038/ncb839 · PMID 12172553 |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Biochemical/genetic (Akt phosphorylation of TSC2) |
| Target | TSC2 / Akt / mTOR |
| Model | Human cell lines |
| Effect | Akt phosphorylates and inactivates TSC2 → relieves mTOR inhibition (links insulin/growth factors to mTORC1) |
In the Atlas
Related topics
Links in the pathway map
- Supports Akt/PKB inhibits TSC1/TSC2
More studies on this topic
- A dynamic network model of mTOR signaling reveals TSC-independent mTORC2 regulation (2012)
- Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway (2002)
- The phosphoinositide 3-kinase pathway (2002)
- IGF2BP3-Mediated m6A Modification of OLR1 mRNA Promotes Immune Evasion in CRC via the PI3K/AKT/mTOR Pathway (2026)
Learn the biology
Want to understand the biology behind this study? → Rheb — The Critical Regulator
Was this page useful?
Thank you. Your answer was counted anonymously.